# Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2014

- Company: [Champions Oncology, Inc.](/companies/csbr.md) (CIK 771856)
- Form: 10-Q
- Filed: 2014-03-14
- Accepted by EDGAR: Mar 14, 2014, 17:01 ET
- Period: 2014-01-31
- Accession: 0001144204-14-015818
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/771856/000114420414015818/v370638_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/771856/000114420414015818/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-01-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2013-11-01 to 2014-01-31 | $535.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2013-05-01 to 2014-01-31 | $1.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2013-11-01 to 2014-01-31 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-05-01 to 2014-01-31 | −$3.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-11-01 to 2014-01-31 | $5.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-05-01 to 2014-01-31 | $13.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-11-01 to 2014-01-31 | −$574.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-05-01 to 2014-01-31 | −$5.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months, 2013-05-01 to 2014-01-31 | −$3.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2013-05-01 to 2014-01-31 | $164.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-01-31 | $5.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-01-31 | $9.2m | us-gaap:AssetsCurrent |
| Total assets | at 2014-01-31 | $10.5m | us-gaap:Assets |
| Current liabilities | at 2014-01-31 | $3.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-01-31 | $6.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-01-31 | $4.5m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/771856/000114420414015818/v370638_10q.htm

Filed Mar 14, 2014.
Source: SEC EDGAR, the filing index for accession 0001144204-14-015818. Last ingested by Listed: Nov 10, 2026, 03:33 ET. No prices; not investment advice.
